Other Species / Isoforms
  YT521 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S35-p
DELYNPEsEQDKNEK
0 3
YT521 (human) DELYNPEsEQDKNEK S35-p
YT521 iso2 (human) DELYNPESEQDKNEK S35
YT521 (mouse) DELYNPESEQDKNEK S35
YT521 (rat) DELYNPEsEQDKNEK S35-p
K48-ac
EKKGSKRksDRMEsT
0 1
YT521 (human) EKKGSKRksDRMEsT K48-ac
YT521 iso2 (human) EKKGSKRKSDRMEST K48
YT521 (mouse) EKKGSKRKSERMEsT K48
YT521 (rat) EKKGSKRKSERMESI K48
S49-p
KKGSKRksDRMEsTD
0 1
YT521 (human) KKGSKRksDRMEsTD S49-p
YT521 iso2 (human) KKGSKRKSDRMESTD S49
YT521 (mouse) KKGSKRKSERMEsTD S49
YT521 (rat) KKGSKRKSERMESID S49
S54-p
RksDRMEsTDTkRQK
Upstream
0 7
Treatment
  • ischemia
YT521 (human) RksDRMEsTDTkRQK S54-p
YT521 iso2 (human) RKSDRMESTDTKRQK S54
YT521 (mouse) RKSERMEsTDTKRQK S54-p
YT521 (rat) RKSERMESIDTKRQk S54
K58-ac
RMEsTDTkRQKPSVH
0 2
YT521 (human) RMEsTDTkRQKPSVH K58-ac
YT521 iso2 (human) RMESTDTKRQKPSVH K58
YT521 (mouse) RMEsTDTKRQKPSIH K58
YT521 (rat) RMESIDTKRQkPSIH K58
K61
sTDTkRQKPSVHSRQ
0 1
YT521 (human) sTDTkRQKPSVHSRQ K61
YT521 iso2 (human) STDTKRQKPSVHSRQ K61
YT521 (mouse) sTDTKRQKPSIHSRQ K61
YT521 (rat) SIDTKRQkPSIHSRQ K61-ac
S71-p
VHSRQLVskPLSSSV
Upstream
0 1
Treatment
  • nocodazole
YT521 (human) VHSRQLVskPLSSSV S71-p
YT521 iso2 (human) VHSRQLVSKPLSSSV S71
YT521 (mouse) IHSRQLISKPLSSSV S71
YT521 (rat) IHSRQLISkPLSSSV S71
K72-ac
HSRQLVskPLSSSVS
0 2
YT521 (human) HSRQLVskPLSSSVS K72-ac
YT521 iso2 (human) HSRQLVSKPLSSSVS K72
YT521 (mouse) HSRQLISKPLSSSVS K72
YT521 (rat) HSRQLISkPLSSSVS K72-ac
K82-ac
SSSVSNNkRIVSTKG
0 4
YT521 (human) SSSVSNNkRIVSTKG K82-ac
YT521 iso2 (human) SSSVSNNKRIVSTKG K82
YT521 (mouse) SSSVSNNKRIVSTkG K82
YT521 (rat) SSSVSNNkRIVSTKG K82-ac
K88
NkRIVSTKGKSATEy
0 1
YT521 (human) NkRIVSTKGKSATEy K88
YT521 iso2 (human) NKRIVSTKGKSATEY K88
YT521 (mouse) NKRIVSTkGKSVTEY K88-ac
YT521 (rat) NkRIVSTKGkSVTEY K88
K90
RIVSTKGKSATEykN
0 1
YT521 (human) RIVSTKGKSATEykN K90
YT521 iso2 (human) RIVSTKGKSATEYKN K90
YT521 (mouse) RIVSTkGKSVTEYKN K90
YT521 (rat) RIVSTKGkSVTEYKN K90-ac
Y95-p
KGKSATEykNEEyQR
0 1
YT521 (human) KGKSATEykNEEyQR Y95-p
YT521 iso2 (human) KGKSATEYKNEEYQR Y95
YT521 (mouse) kGKSVTEYKNEEYQR Y95
YT521 (rat) KGkSVTEYKNEEYQR Y95
K96-sm
GKSATEykNEEyQRS
0 1
YT521 (human) GKSATEykNEEyQRS K96-sm
YT521 iso2 (human) GKSATEYKNEEYQRS K96
YT521 (mouse) GKSVTEYKNEEYQRS K96
YT521 (rat) GkSVTEYKNEEYQRS K96
Y100-p
TEykNEEyQRSERNK
0 16
YT521 (human) TEykNEEyQRSERNK Y100-p
YT521 iso2 (human) TEYKNEEYQRSERNK Y100
YT521 (mouse) TEYKNEEYQRSErNK Y100
YT521 (rat) TEYKNEEYQRSERNK Y100
R105
EEyQRSERNKRLDAD
0 1
YT521 (human) EEyQRSERNKRLDAD R105
YT521 iso2 (human) EEYQRSERNKRLDAD R105
YT521 (mouse) EEYQRSErNKrLDAD R105-m1
YT521 (rat) EEYQRSERNKRLDAD R105
R108
QRSERNKRLDADRKI
0 1
YT521 (human) QRSERNKRLDADRKI R108
YT521 iso2 (human) QRSERNKRLDADRKI R108
YT521 (mouse) QRSErNKrLDADRKI R108-m1
YT521 (rat) QRSERNKRLDADRKI R108
S118-p
ADRKIRLsssAsREP
Upstream
0 20
Treatment
  • ischemia
  • MLN8054
  • nocodazole
YT521 (human) ADRKIRLsssAsREP S118-p
YT521 iso2 (human) ADRKIRLSSSASREP S118
YT521 (mouse) ADRKIRLsssSsREP S118-p
YT521 (rat) ADRKIRLSSsSSREP S118
S119-p
DRKIRLsssAsREPY
Upstream
0 28
Treatment
  • rapamycin
YT521 (human) DRKIRLsssAsREPY S119-p
YT521 iso2 (human) DRKIRLSSSASREPY S119
YT521 (mouse) DRKIRLsssSsREPY S119-p
YT521 (rat) DRKIRLSSsSSREPY S119
S120-p
RKIRLsssAsREPYK
Upstream
0 11
Treatment
  • EGF
  • rapamycin
YT521 (human) RKIRLsssAsREPYK S120-p
YT521 iso2 (human) RKIRLSSSASREPYK S120
YT521 (mouse) RKIRLsssSsREPYK S120-p
YT521 (rat) RKIRLSSsSSREPYK S120-p
S122-p
IRLsssAsREPYKNQ
0 9
YT521 (human) IRLsssAsREPYKNQ S122-p
YT521 iso2 (human) IRLSSSASREPYKNQ S122
YT521 (mouse) IRLsssSsREPYKSQ S122-p
YT521 (rat) IRLSSsSSREPYKSQ S122
S146-p
DPERRAKsPtPDGsE
Upstream
0 44
Treatment
  • angiotensin-(1-7)
  • nocodazole
YT521 (human) DPERRAKsPtPDGsE S146-p
YT521 iso2 (human) DPERRAKSPTPDGSE S146
YT521 (mouse) DSERRAKsPtPDGsE S146-p
YT521 (rat) DSERRAKsPtPDGSE S146-p
T148-p
ERRAKsPtPDGsERI
Upstream
0 41
Treatment
  • angiotensin-(1-7)
  • nocodazole
YT521 (human) ERRAKsPtPDGsERI T148-p
YT521 iso2 (human) ERRAKSPTPDGSERI T148
YT521 (mouse) ERRAKsPtPDGsERI T148-p
YT521 (rat) ERRAKsPtPDGSERI T148-p
S152-p
KsPtPDGsERIGLEV
0 10
YT521 (human) KsPtPDGsERIGLEV S152-p
YT521 iso2 (human) KSPTPDGSERIGLEV S152
YT521 (mouse) KsPtPDGsERIGLEV S152-p
YT521 (rat) KsPtPDGSERIGLEV S152
S164-p
LEVDRRAsRSSQSSK
0 1
YT521 (human) LEVDRRAsRSSQSSK S164-p
YT521 iso2 (human) LEVDRRASRSSQSSK S164
YT521 (mouse) LEVDRRASRSSQSSK S164
YT521 (rat) LEVDRRASRSSQSSK S164
Y264-p
QKEEGNDyDtRSEAS
0 1
YT521 (human) QKEEGNDyDtRSEAS Y264-p
YT521 iso2 (human) QKEEGNDYDTRSEAS Y264
YT521 (mouse) QKEEGNDYDtRSEAS Y265
YT521 (rat) QKEEGNDYDTRSEAS Y267
T266-p
EEGNDyDtRSEASDs
0 5
YT521 (human) EEGNDyDtRSEASDs T266-p
YT521 iso2 (human) EEGNDYDTRSEASDS T266
YT521 (mouse) EEGNDYDtRSEASDS T267-p
YT521 (rat) EEGNDYDTRSEASDS T269
S273-p
tRSEASDsGsEsVSF
0 3
YT521 (human) tRSEASDsGsEsVSF S273-p
YT521 iso2 (human) TRSEASDSGSESVSF S273
YT521 (mouse) tRSEASDSGSESVSF S274
YT521 (rat) TRSEASDSGSESVSF S276
S275-p
SEASDsGsEsVSFTD
0 3
YT521 (human) SEASDsGsEsVSFTD S275-p
YT521 iso2 (human) SEASDSGSESVSFTD S275
YT521 (mouse) SEASDSGSESVSFTD S276
YT521 (rat) SEASDSGSESVSFTD S278
S277-p
ASDsGsEsVSFTDGS
0 1
YT521 (human) ASDsGsEsVSFTDGS S277-p
YT521 iso2 (human) ASDSGSESVSFTDGS S277
YT521 (mouse) ASDSGSESVSFTDGS S278
YT521 (rat) ASDSGSESVSFTDGS S280
T291-p
SVRSGSGtDGSDEKK
0 1
YT521 (human) SVRSGSGtDGSDEKK T291-p
YT521 iso2 (human) SVRSGSGTDGSDEKK T291
YT521 (mouse) SVRSGSGTDGSDEKK T292
YT521 (rat) SVRSGSGTDGSDEKK T294
S308-p
RKRARGIsPIVFDRs
Upstream
0 86
Treatment
  • nocodazole
YT521 (human) RKRARGIsPIVFDRs S308-p
YT521 iso2 (human) RKRARGIsPIVFDRS S308-p
YT521 (mouse) RKRARGIsPIVFDRs S309-p
YT521 (rat) RKRARGIsPIVFDRS S311-p
S315-p
sPIVFDRsGssAsEs
Upstream
0 11
Treatment
  • nocodazole
YT521 (human) sPIVFDRsGssAsEs S315-p
YT521 iso2 (human) sPIVFDRSGSsAsES S315
YT521 (mouse) sPIVFDRsGssAsES S316-p
YT521 (rat) sPIVFDRSGsSASES S318
S317-p
IVFDRsGssAsEsyA
Upstream
0 13
Treatment
  • nocodazole
YT521 (human) IVFDRsGssAsEsyA S317-p
YT521 iso2 (human) IVFDRSGSsAsESYA S317
YT521 (mouse) IVFDRsGssAsESYA S318-p
YT521 (rat) IVFDRSGsSASESYA S320-p
S318-p
VFDRsGssAsEsyAG
Upstream
0 8
Treatment
  • nocodazole
YT521 (human) VFDRsGssAsEsyAG S318-p
YT521 iso2 (human) VFDRSGSsAsESYAD S318-p
YT521 (mouse) VFDRsGssAsESYAG S319-p
YT521 (rat) VFDRSGsSASESYAG S321
S320-p
DRsGssAsEsyAGsE
0 6
YT521 (human) DRsGssAsEsyAGsE S320-p
YT521 iso2 (human) DRSGSsAsESYADQt S320-p
YT521 (mouse) DRsGssAsESYAGSE S321-p
YT521 (rat) DRSGsSASESYAGSE S323
S322-p
sGssAsEsyAGsEKK
0 1
YT521 (human) sGssAsEsyAGsEKK S322-p
YT521 iso2 (human) SGSsAsESYADQtsK S322
YT521 (mouse) sGssAsESYAGSEKK S323
YT521 (rat) SGsSASESYAGSEKK S325
Y323-p
GssAsEsyAGsEKKH
0 1
YT521 (human) GssAsEsyAGsEKKH Y323-p
YT521 iso2 (human) GSsAsESYADQtsKL Y323
YT521 (mouse) GssAsESYAGSEKKH Y324
YT521 (rat) GsSASESYAGSEKKH Y326
S326-p
AsEsyAGsEKKHEKL
0 4
YT521 (human) AsEsyAGsEKKHEKL S326-p
YT521 iso2 (human) gap -
YT521 (mouse) AsESYAGSEKKHEKL S327
YT521 (rat) ASESYAGSEKKHEKL S329
S334-p
EKKHEKLsSSVRAVR
0 1
YT521 (human) EKKHEKLsSSVRAVR S334-p
YT521 iso2 (human) gap -
YT521 (mouse) EKKHEKLSSSVRAVR S335
YT521 (rat) EKKHEKLSSSVRAVR S337
T345-p
RAVRKDQtsKLkYVL
0 3
YT521 (human) RAVRKDQtsKLkYVL T345-p
YT521 iso2 (human) sESYADQtsKLKYVL T327-p
YT521 (mouse) RAVRKDQTSKLKYVL T346
YT521 (rat) RAVRKDQTSKLKYVL T348
S346-p
AVRKDQtsKLkYVLQ
0 2
YT521 (human) AVRKDQtsKLkYVLQ S346-p
YT521 iso2 (human) ESYADQtsKLKYVLQ S328-p
YT521 (mouse) AVRKDQTSKLKYVLQ S347
YT521 (rat) AVRKDQTSKLKYVLQ S349
K349-ac
KDQtsKLkYVLQDAR
0 1
YT521 (human) KDQtsKLkYVLQDAR K349-ac
YT521 iso2 (human) ADQtsKLKYVLQDAR K331
YT521 (mouse) KDQTSKLKYVLQDAR K350
YT521 (rat) KDQTSKLKYVLQDAR K352
K372-ub
HENVSLAkAKGVWST
0 1
YT521 (human) HENVSLAkAKGVWST K372-ub
YT521 iso2 (human) HENVSLAKAKGVWST K354
YT521 (mouse) HENVSLAKAKGVWST K373
YT521 (rat) HENVSLAKAKGVWST K375
S416-p
FQGFARLssEsHHGG
0 1
YT521 (human) FQGFARLssEsHHGG S416-p
YT521 iso2 (human) FQGFARLSSESHHGG S398
YT521 (mouse) FQGFARLSsEsHHGG S417
YT521 (rat) FQGFARLSSESHHGG S419
S417-p
QGFARLssEsHHGGs
0 6
YT521 (human) QGFARLssEsHHGGs S417-p
YT521 iso2 (human) QGFARLSSESHHGGS S399
YT521 (mouse) QGFARLSsEsHHGGs S418-p
YT521 (rat) QGFARLSSESHHGGS S420
S419-p
FARLssEsHHGGsPI
0 6
YT521 (human) FARLssEsHHGGsPI S419-p
YT521 iso2 (human) FARLSSESHHGGSPI S401
YT521 (mouse) FARLSsEsHHGGsPI S420-p
YT521 (rat) FARLSSESHHGGSPI S422
S424-p
sEsHHGGsPIHWVLP
Upstream
0 71
Treatment
  • nocodazole
YT521 (human) sEsHHGGsPIHWVLP S424-p
YT521 iso2 (human) SESHHGGSPIHWVLP S406
YT521 (mouse) sEsHHGGsPIHWVLP S425-p
YT521 (rat) SESHHGGSPIHWVLP S427
S435-p
WVLPAGMsAKMLGGV
Upstream
0 2
Treatment
  • nocodazole
YT521 (human) WVLPAGMsAKMLGGV S435-p
YT521 iso2 (human) WVLPAGMSAKMLGGV S417
YT521 (mouse) WVLPAGMSAKMLGGV S436
YT521 (rat) WVLPAGMSAKMLGGV S438
K469-ub
TNPWNEHkPVkIGRD
0 1
YT521 (human) TNPWNEHkPVkIGRD K469-ub
YT521 iso2 (human) TNPWNEHKPVKIGRD K451
YT521 (mouse) TNPWNEHKPVKIGRD K470
YT521 (rat) TNPWNEHKPVKIGRD K472
K469-sm
TNPWNEHkPVkIGRD
0 2
YT521 (human) TNPWNEHkPVkIGRD K469-sm
YT521 iso2 (human) TNPWNEHKPVKIGRD K451
YT521 (mouse) TNPWNEHKPVKIGRD K470
YT521 (rat) TNPWNEHKPVKIGRD K472
K472-ub
WNEHkPVkIGRDGQE
0 1
YT521 (human) WNEHkPVkIGRDGQE K472-ub
YT521 iso2 (human) WNEHKPVKIGRDGQE K454
YT521 (mouse) WNEHKPVKIGRDGQE K473
YT521 (rat) WNEHKPVKIGRDGQE K475
S515-p
RHKRRMHsQPRsRGR
Upstream
0 34
Treatment
  • nocodazole
YT521 (human) RHKRRMHsQPRsRGR S515-p
YT521 iso2 (human) RHKRRMHSQPRSRGR S497
YT521 (mouse) RHKRRMHsQPRSRGR S516-p
YT521 (rat) RHKRRMHSQPRSRGR S518
S519-p
RMHsQPRsRGRPSRR
Upstream
0 1
Treatment
  • nocodazole
YT521 (human) RMHsQPRsRGRPSRR S519-p
YT521 iso2 (human) RMHSQPRSRGRPSRR S501
YT521 (mouse) RMHsQPRSRGRPSRR S520
YT521 (rat) RMHSQPRSRGRPSRR S522
Y540-p
GRRRPEDyDIHNsRK
0 42
YT521 (human) GRRRPEDyDIHNsRK Y540-p
YT521 iso2 (human) GRRRPEDYDIHNSRK Y522
YT521 (mouse) GRRRPEDyDIHNSRK Y541-p
YT521 (rat) GRRRPEDyDIHNSRK Y543-p
S545-p
EDyDIHNsRKKPRID
Upstream
0 6
Treatment
  • nocodazole
YT521 (human) EDyDIHNsRKKPRID S545-p
YT521 iso2 (human) EDYDIHNSRKKPRID S527
YT521 (mouse) EDyDIHNSRKKPRID S546
YT521 (rat) EDyDIHNSRKKPRID S548
Y553-p
RKKPRIDyPPEFHQR
0 1
YT521 (human) RKKPRIDyPPEFHQR Y553-p
YT521 iso2 (human) RKKPRIDYPPEFHQR Y535
YT521 (mouse) RKKPRIDYPPEFHQR Y554
YT521 (rat) RKKPRIDYPPEFHQR Y556
Y569-p
GYLKDPRyQEVDRRF
0 1
YT521 (human) GYLKDPRyQEVDRRF Y569-p
YT521 iso2 (human) GYLKDPRYQEVDRRF Y551
YT521 (mouse) GYVKDPRYQEVDSFT Y570
YT521 (rat) GYLKDPRYQEVDSFT Y572
S577-p
QEVDRRFsGVRRDVF
Upstream
0 4
Treatment
  • ZK-Thiazolidinone
YT521 (human) QEVDRRFsGVRRDVF S577-p
YT521 iso2 (human) QEVDRRFSGVRRDVF S559
YT521 (mouse) LIPNRRFSGVRRDVF S586
YT521 (rat) LIPNRRFsGVRRDVF S588-p
S588-p
RDVFLNGsYNDYVRE
Upstream
0 3
Treatment
  • ischemia
YT521 (human) RDVFLNGsYNDYVRE S588-p
YT521 iso2 (human) RDVFLNGSYNDYVRE S570
YT521 (mouse) RDVFLNGsYNDYVRE S597-p
YT521 (rat) RDVFLNGSYNDYVRE S599
Y656-p
RDKRVHDyDMRVDDF
0 4
YT521 (human) RDKRVHDyDMRVDDF Y656-p
YT521 iso2 (human) RDKRVHDYDMRVDDF Y638
YT521 (mouse) RDKRVHDYDMRVDDF Y665
YT521 (rat) RDKRVHDYDMRVDDF Y667
T667-p
VDDFLRRtQAVVsGR
0 1
YT521 (human) VDDFLRRtQAVVsGR T667-p
YT521 iso2 (human) VDDFLRRTQAVVSGR T649
YT521 (mouse) VDDFLRRTQAVVSGR T676
YT521 (rat) VDDFLRRTQAVVSGR T678
S672-p
RRtQAVVsGRRSRPR
0 1
YT521 (human) RRtQAVVsGRRSRPR S672-p
YT521 iso2 (human) RRTQAVVSGRRSRPR S654
YT521 (mouse) RRTQAVVSGRRSRPR S681
YT521 (rat) RRTQAVVSGRRSRPR S683
R705
ERDRGRDRERERERL
0 1
YT521 (human) ERDRGRDRERERERL R705
YT521 iso2 (human) ERDRGRDRERERERL R687
YT521 (mouse) ERDRGRDrErERERI R714-m1
YT521 (rat) ERDRGRDRERERERI R716
R707
DRGRDRERERERLCD
0 1
YT521 (human) DRGRDRERERERLCD R707
YT521 iso2 (human) DRGRDRERERERLCD R689
YT521 (mouse) DRGRDrErERERICD R716-m1
YT521 (rat) DRGRDRERERERICD R718